Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
6.85
+0.75 (12.30%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Jaguar Health Employees
Jaguar Health had 49 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
49
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$238,551
Profits / Employee
-$785,551
Market Cap
4.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
JAGX News
- 6 days ago - Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress - Accesswire
- 8 days ago - Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting - Accesswire
- 15 days ago - Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product - Accesswire
- 19 days ago - Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Accesswire
- 22 days ago - Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - Accesswire
- 23 days ago - Jaguar Health, Inc. (JAGX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - Accesswire
- 26 days ago - 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Accesswire